Listed pharmaceutical companies weakened in profitability while recording similar amount of sales with the average year

Published: 2017-03-10 14:13:47

Updated: 2017-03-10 14:13:47

Although listed pharmaceutical companies recorded a growth rate that is approximate to 7%, it was analyzed they were weakened in profitability.

According to the Yakup Shinmoon’s analysis result of 57 KOSPI and KOSDAQ listed pharmaceutical companies’ operating results in 2016, their sales grew 7.3% up compared to 2015. <excluding holding companies for the analysis>

However, their operating pro...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.